Anderson Ryan

Anderson Ryan is a highly experienced professional in the field of oncology and translational science, currently serving as the Scientific Co-Founder and Scientific Advisory Board Member at FAST BIOPHARMA LTD since March 2022. Prior to this role, Anderson was an Honorary Researcher and Associate Professor at the University of Oxford's Department of Oncology, contributing from April 2010 to February 2024. Additional experience includes leadership positions such as VP Head of Oncology at Mission Therapeutics and Head of Translational Science at Medicines Discovery Catapult. Previous roles also encompass significant positions at AstraZeneca, Zeneca, and academic appointments at various universities, including the University of Manchester and the University of Cambridge. Anderson holds a BSc in Genetics from the University of Nottingham and completed further studies at the University of Oxford.